The House joined the Senate in passing Senate Bill 55 unanimously last week. Only Representative Tim Dukes was absent, and thus unable to vote yes. Once Governor Carney signs this bill, epinephrine autoinjectors will be supplied to public and charter schools if an employee or school agent has completed a training program on how to use the medicine.
Epinephrine autoinjectors help treat someone who is experiencing a severe allergic reaction, known as anaphylaxis, which can result in swelling of the throat or airway.
|Senate Bill 55 Sponsors||Yes Votes||No Votes|
|Sokola Hansen Paradee Pettyjohn Pinkney Townsend Lopez||Senate passed 21-0. Brown Ennis Gay Hansen Lockman Mantzavinos Paradee Pinkney Poore S.McBride Sokola Sturgeon Townsend Walsh Bonini Hocker Lawson Lopez Pettyjohn Richardson Wilson|
|Minor-Brown Dorsey-Walker Baumbach Bennett Heffernan K.Johnson Kowalko Lambert Lynn Osienski Shupe Gray||Houses Passes 40-0-1. Baumbach, Bennett, Bentz, Bolden, Brady, Bush, Carson, Chukwuocha, Cooke, Dorsey Walker, Griffith Heffernan K.Johnson K.Williams Kowalko Lambert Longhurst Lynn Matthews Minor-Brown Mitchell Morrison Osienski S.Moore Schwartzkopf Wilson-Anton Briggs King Bush Collins D.Short Gray Hensley M.Smith Morris Postles Ramone Shupe Smyk Spiegelman Vanderwende Yearick||Dukes (Absent)|
|Current Status:||Sent to Governor Carney for his signature.|
“Not only can this legislation prevent deaths here in Delaware, it can make a huge difference in the lives of students, staff, and parents who live in constant fear of a life-threatening allergic reaction,” said Senate President Pro Tempore David Sokola. “This bill builds on past efforts to provide emergency medications in our K-12 schools and I believe it will lead to colleges and universities that are safer and more accessible to all students. That’s a noble goal, one that I don’t doubt will also pass the House and earn the Governor’s signature this year.”
The bill requires employees to complete a training program before being certified to administer or provide epinephrine to someone experiencing anaphylaxis. Training must include how to recognize symptoms of severe allergic reactions, how to store and use epinephrine autoinjectors, associated risks, and other considerations. Certifications under this legislation would last for two years.
The bill also exempts individuals who provide or administer epinephrine from liability under existing good Samaritan law.